Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Healthcare Bull 3X Direxion ETF (CURE)

Healthcare Bull 3X Direxion ETF (CURE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2019 and Provides Business Update

OpGen, Inc. (Nasdaq: OPGN, "OpGen"), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, announced today that total revenue for...

OPGN : 1.50 (+1.35%)
CURE : 65.38 (+4.41%)
Best & Worst Leveraged ETFs of Last Week

Inside the top-and-worst-performing leveraged ETFs of last week.

SPY : 316.64 (+1.28%)
QQQ : 219.02 (+0.98%)
DIA : 273.70 (+1.11%)
CWEB : 29.29 (+0.10%)
YINN : 17.63 (+6.46%)
CURE : 65.38 (+4.41%)
UBOT : 11.21 (+4.09%)
HIBL : 23.21 (+2.52%)
OpGen Achieves Key Milestone in Planned Business Combination with Curetis

-- Transaction unanimously supported by the boards of OpGen and Curetis and supported by debt holders

OPGN : 1.50 (+1.35%)
CURE : 65.38 (+4.41%)
5 Top-Performing Leveraged ETFs of November

Inside the best five best leveraged ETFs of November.

LABU : 51.21 (+5.18%)
TECL : 250.62 (+4.89%)
BNKU : 55.56 (+0.51%)
CURE : 65.38 (+4.41%)
FNGU : 85.59 (+5.67%)
Best Leveraged ETF Areas of Last Week

These leveraged ETFs posted solid gains last week.

UBIO : 30.91 (+6.00%)
LABU : 51.21 (+5.18%)
BOIL : 5.90 (+2.43%)
RUSL : 55.38 (+2.31%)
JNUG : 80.67 (-1.03%)
INDL : 61.00 (+1.87%)
CURE : 65.38 (+4.41%)
PILL : 22.00 (-0.50%)
UGAZ : 43.16 (+5.27%)
Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses

-- Combined company to be headquartered in Gaithersburg, MD, USA

OPGN : 1.50 (+1.35%)
CURE : 65.38 (+4.41%)
Curetis to Present at Solebury Trout European Biotech Investor Day in NYC

Amsterdam, the Netherlands, San Diego, CA, USA, and Holzgerlingen, Germany, July 25, 2019, 08:00 am CEST - Curetis N.V. (the "Company" and, together with Curetis USA Inc. and Curetis GmbH, "Curetis"),...

DB : 9.70 (+3.97%)
CURE : 65.38 (+4.41%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.47 , SEDG +0.51 , THC +0.88 , TER +1.17 , LITE +1.66
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar